Viewing Study NCT01928459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2026-02-03 @ 2:41 PM
Study NCT ID: NCT01928459
Status: COMPLETED
Last Update Posted: 2020-12-09
First Post: 2013-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1b Trial of BGJ398/BYL719 in Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
None Metastatic Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BGJ398 View
None BYL719 View
None advanced solid tumor View
None metastatic breast cancer View
None PK3CA View
None FGFR View
None fibroblast growth factor receptor View